Tuesday, 20 January 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 20 January 2026
News

Guess who's moving to the CBD?

Posted 16 January 2025 AM

AbbVie is relocating its Australian headquarters to the Sydney CBD at the end of this year, bringing the company's Therapeutics and Aesthetics teams under the one roof for the first time.

The new address is 321 Kent Street, a 21-storey tower in the heart of the CBD, known for its glass facade and large forecourt, views of Darling Harbour and natural light.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (10)

Access & Reimbursement (1)

Clinical & Medical, R&D (4)

Regulatory, Pharmacovigilance & QA (3)

Other (10)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.